Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Xilis has raised $19.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Xilis's investors include Pear VC, 8VC, FPV Ventures, EQT, Felicis.
Xilis is headquartered in Durham, United States.
Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Xilis is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xilis — Funding & Investors." VCBacked, April 25, 2025, https://www.vcbacked.co/company/xilis. Accessed November 17, 2026.
VCBacked. (2025). Xilis — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/xilis
{{cite web |title=Xilis — Funding & Investors |url=https://www.vcbacked.co/company/xilis |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Xilis? Request a listing update